Xiaoli Shan

机构：Shanghai University of Traditional Chinese Medicine, Weifang People's Hospital

发表论文 27 篇 · 总被引 539 次 · h-index 13

代表论文

• Notoginsenoside R1-loaded mesoporous silica nanoparticles targeting the site of injury through inflammatory cells improves heart repair after myocardial infarction (2022 · Redox Biology · 被引 170)
• Ophiopogonin D alleviates diabetic myocardial injuries by regulating mitochondrial dynamics (2021 · Journal of Ethnopharmacology · 被引 56)
• Stachydrine Ameliorates Cardiac Fibrosis Through Inhibition of Angiotensin II/Transformation Growth Factor β1 Fibrogenic Axis (2019 · Frontiers in Pharmacology · 被引 47)
• Shengmai San Alleviates Diabetic Cardiomyopathy Through Improvement of Mitochondrial Lipid Metabolic Disorder (2018 · Cellular Physiology and Biochemistry · 被引 40)
• Stachydrine hydrochloride alleviates pressure overload-induced heart failure and calcium mishandling on mice (2019 · Journal of Ethnopharmacology · 被引 25)
• Stachydrine hydrochloride suppresses phenylephrine-induced pathological cardiac hypertrophy by inhibiting the calcineurin/nuclear factor of activated T-cell signalling pathway (2020 · European Journal of Pharmacology · 被引 21)